Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,912.00
Bid: 4,900.00
Ask: 4,904.00
Change: 2.00 (0.04%)
Spread: 4.00 (0.082%)
Open: 4,894.00
High: 4,912.00
Low: 4,882.00
Prev. Close: 4,910.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Nov 2010 07:00

RNS Number : 3867W
Intertek Group PLC
18 November 2010
 



18 November 2010, 7:00am London (UK)

Intertek Group plc

Interim Management Statement

 

Intertek Group plc ("Intertek"), the leading provider of quality and safety services to a wide range of industries around the world, today releases its Interim Management Statement for its results from 1 January to 31 October 2010 ("the period"). All comments in this statement reflect comparisons with the same period during 2009. The Group's full year results to 31 December 2010 will be announced on 7 March 2011.

 

At constant exchange rates, organic revenue for the period increased by 6.5%. After taking into account acquisitions and a net favourable currency effect, total reported revenue increased by 9.2% in the same period.

 

The Group has seen market conditions strengthen across many parts of its business in the second half and all divisions continued to grow revenues in the first ten months of the year. The Group has increased investment to capture growth opportunities, and since April when markets started their good recovery, the Group has increased headcount by around 1,500 (6%).

 

Consumer Goods is showing an improved rate of growth since the half year, now that the comparables of exceptionally high demand for toy testing following enactment of the Consumer Product Safety Improvement Act in the US have ended. New labs have been added in various areas, in particular in food. Revenues in Commercial & Electrical increased, with the strongest growth in lighting and renewable energy product testing. Oil, Chemical & Agri, Analytical Services and Industrial Services revenues all grew well and Minerals exhibited very strong growth. However, some markets are still showing weakness including oil cargo inspection in North America, industrial infrastructure, building products and pharmaceutical.

 

These overall market conditions and revenue growth are leading to an improvement in the second half adjusted operating profit margin compared to the first half. Intertek expects the second half margin to be in-line with that of the equivalent prior year period resulting in a full-year margin slightly below the prior year.

 

Six acquisitions for a consideration of £40 million have been completed year-to-date and further acquisitions are expected during the remainder of the year. The balance sheet remains healthy with net debt as at 31 October 2010 of £186 million compared to £240 million at 30 June.

 

Wolfhart Hauser, Chief Executive Officer, said: "We are seeing good progress towards more normal trading conditions in many of our business segments that had been weaker during the global downturn. We expect our full year rate of organic revenue growth to be at the high end of the mid single digits range. Looking forward, we expect this year-to-date level of organic growth to continue into 2011 supplemented by bolt-on acquisitions. We remain cautious on further growth acceleration due to the uncertain effect of austerity measures on economies in many countries."

 

Contacts

Aston Swift / Sarah Ogilvie

Telephone: +44 (0) 20 7396 3400

aston.swift@intertek.com / sarah.ogilvie@intertek.com

 

Richard Mountain, Financial Dynamics

Telephone: +44 (0) 20 7269 7291

richard.mountain@fd.com

 

Notes to Editors

ABOUT INTERTEK

Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 26,000 people in more than 100 countries around the world.

Intertek Group plc (LSE: ITRK) is listed on the London Stock Exchange and is a constituent of the FTSE 100 index.

 

www.intertek.com 

This Interim Management Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this Interim Management Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. Statements contained in this Interim Management Statement are based on the knowledge and information available to the Company's Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Interim Management Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Interim Management Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBIUBBGGR
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.